Clinical Trial Update: Pharmacologic Optimization of Voriconazole [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating pharmacologic optimization of voriconazole for invasive fungal infections in patients with he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Invasive Fungal Infection

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Jan-Willem C Alffenaar | Conditions: Invasive Fungal Infection, Hematological Malignancy | Phase 3 | Status: COMPLETED